AIMS/HYPOTHESIS: Non-invasive measures of aortic stiffness reflect vascular senescence and predict outcome in diabetes. Glucose-mediated elastic artery sclerosis may play an integral role in the development of macrovascular complications. We used carotid-femoral pulse wave velocity ((cf)PWV) to quantify independent associations of fasting glucose, post-challenge glucose and derived insulin resistance (HOMA-IR) with aortic stiffness. METHODS: (cf)PWV was measured using a 4 MHz continuous wave Doppler ultrasound probe within groups with newly identified age- and sex-matched normal glucose metabolism (NGM), impaired glucose regulation (IGR) and diabetes mellitus populations (n = 570, mean age 59.1, 56% male). RESULTS: After multivariate adjustment, IGR and diabetes were associated with significant aortic stiffening compared with NGM (adjusted (cf)PWV+/-SE: NGM, 9.15 +/- 0.12 m/s; IGR 9.76 +/- 0.11 m/s, p < 0.001; diabetes, 9.89 +/- 0.12 m/s, p < 0.001). IGR stratification indicated that impaired fasting glucose (IFG; 9.71 +/- 0.12 m/s) and post-challenge (impaired glucose tolerance; 9.82 +/- 0.24 m/s) categories had similar (cf)PWV (p = 0.83). Modelled predictors of (cf)PWV were used to assess independent metabolic associations with arterial stiffness. Fasting glucose concentration (beta = 0.10; 95% CI 0.05, 0.18; p = 0.003), 2 h post-challenge glucose (beta = 0.14; 95% CI 0.02, 0.23; p < 0.001) and HOMA-IR (beta = 0.20, 95% CI 0.05, 0.53; p < 0.001) were independently related to (cf)PWV after adjustment for age, sex, mean arterial pressure, heart rate, body mass index, renal function and antihypertensive medication. CONCLUSIONS/ INTERPRETATION: IGR characterised by fasting or post-challenge hyperglycaemia is associated with significant vascular stiffening. Post-challenge glucose and HOMA-IR are the most powerful metabolic predictors of arterial stiffness, implying hyperglycaemic excursion and insulin resistance play important roles in the pathogenesis of arteriosclerosis.
AIMS/HYPOTHESIS: Non-invasive measures of aortic stiffness reflect vascular senescence and predict outcome in diabetes. Glucose-mediated elastic artery sclerosis may play an integral role in the development of macrovascular complications. We used carotid-femoral pulse wave velocity ((cf)PWV) to quantify independent associations of fasting glucose, post-challenge glucose and derived insulin resistance (HOMA-IR) with aortic stiffness. METHODS: (cf)PWV was measured using a 4 MHz continuous wave Doppler ultrasound probe within groups with newly identified age- and sex-matched normal glucose metabolism (NGM), impaired glucose regulation (IGR) and diabetes mellitus populations (n = 570, mean age 59.1, 56% male). RESULTS: After multivariate adjustment, IGR and diabetes were associated with significant aortic stiffening compared with NGM (adjusted (cf)PWV+/-SE: NGM, 9.15 +/- 0.12 m/s; IGR 9.76 +/- 0.11 m/s, p < 0.001; diabetes, 9.89 +/- 0.12 m/s, p < 0.001). IGR stratification indicated that impaired fasting glucose (IFG; 9.71 +/- 0.12 m/s) and post-challenge (impaired glucose tolerance; 9.82 +/- 0.24 m/s) categories had similar (cf)PWV (p = 0.83). Modelled predictors of (cf)PWV were used to assess independent metabolic associations with arterial stiffness. Fasting glucose concentration (beta = 0.10; 95% CI 0.05, 0.18; p = 0.003), 2 h post-challenge glucose (beta = 0.14; 95% CI 0.02, 0.23; p < 0.001) and HOMA-IR (beta = 0.20, 95% CI 0.05, 0.53; p < 0.001) were independently related to (cf)PWV after adjustment for age, sex, mean arterial pressure, heart rate, body mass index, renal function and antihypertensive medication. CONCLUSIONS/ INTERPRETATION: IGR characterised by fasting or post-challenge hyperglycaemia is associated with significant vascular stiffening. Post-challenge glucose and HOMA-IR are the most powerful metabolic predictors of arterial stiffness, implying hyperglycaemic excursion and insulin resistance play important roles in the pathogenesis of arteriosclerosis.
Authors: Thomas Weber; Marcus Ammer; Martin Rammer; Audrey Adji; Michael F O'Rourke; Siegfried Wassertheurer; Stefan Rosenkranz; Bernd Eber Journal: J Hypertens Date: 2009-08 Impact factor: 4.844
Authors: N Ahluwalia; L Drouet; J-B Ruidavets; B Perret; J Amar; H Boccalon; H Hanaire-Broutin; J Ferrières Journal: Atherosclerosis Date: 2005-08-29 Impact factor: 5.162
Authors: Ronald M A Henry; Piet J Kostense; Annemieke M W Spijkerman; Jacqueline M Dekker; Giel Nijpels; Robert J Heine; Otto Kamp; Nico Westerhof; Lex M Bouter; Coen D A Stehouwer Journal: Circulation Date: 2003-04-14 Impact factor: 29.690
Authors: Isabel Ferreira; Colin A Boreham; Jos W R Twisk; Alison M Gallagher; Ian S Young; Liam J Murray; Coen D A Stehouwer Journal: J Hypertens Date: 2007-05 Impact factor: 4.844
Authors: A Sandbaek; S J Griffin; G Rutten; M Davies; R Stolk; K Khunti; K Borch-Johnsen; N J Wareham; T Lauritzen Journal: Diabetologia Date: 2008-04-29 Impact factor: 10.122
Authors: Chesney K Richter; Ann C Skulas-Ray; Trent L Gaugler; Joshua D Lambert; David N Proctor; Penny M Kris-Etherton Journal: Am J Clin Nutr Date: 2016-12-21 Impact factor: 7.045
Authors: Camila Manrique-Acevedo; Francisco I Ramirez-Perez; Jaume Padilla; Victoria J Vieira-Potter; Annayya R Aroor; Brady J Barron; Dongqing Chen; Dominic Haertling; Cory Declue; James R Sowers; Luis A Martinez-Lemus Journal: Endocrinology Date: 2017-06-01 Impact factor: 4.736
Authors: Laura R Loehr; Michelle L Meyer; Anna K Poon; Elizabeth Selvin; Priya Palta; Hirofumi Tanaka; James S Pankow; Jacqueline D Wright; Michael E Griswold; Lynne E Wagenknecht; Gerardo Heiss Journal: Am J Hypertens Date: 2016-04-11 Impact factor: 2.689